Daiichi Sankyo, Head of Data Governance, R&D: Significance of Data in Drug Development Life Cycle

Daiichi Sankyo, Head of Data Governance, R&D: Significance of Data in Drug Development Life Cycle

Hayes Williams, Head of Data Governance, R&D at Daiichi Sankyo, together with Baz Khuti, President US at Modak, explains the importance of data in his role as a CDO. Williams’ responsibilities in research and development are fully invested in data. From the beginning of basic research to managing clinical trials, quality data management and governance are essential across the company. The overall life cycle of drug development highlights data as a strategic asset in providing the best drug treatments for patients.

Related Stories

No stories found.
CDO Magazine
www.cdomagazine.tech